GR3035860T3 - Transdermal preparation containing a loratidine metabolite with antihistaminic activity - Google Patents

Transdermal preparation containing a loratidine metabolite with antihistaminic activity

Info

Publication number
GR3035860T3
GR3035860T3 GR20010400711T GR20010400711T GR3035860T3 GR 3035860 T3 GR3035860 T3 GR 3035860T3 GR 20010400711 T GR20010400711 T GR 20010400711T GR 20010400711 T GR20010400711 T GR 20010400711T GR 3035860 T3 GR3035860 T3 GR 3035860T3
Authority
GR
Greece
Prior art keywords
preparation containing
transdermal preparation
antihistaminic activity
loratidine
loratidine metabolite
Prior art date
Application number
GR20010400711T
Other languages
English (en)
Inventor
Karin Klokkers
Wilfried Fischer
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of GR3035860T3 publication Critical patent/GR3035860T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20010400711T 1994-12-02 2001-05-15 Transdermal preparation containing a loratidine metabolite with antihistaminic activity GR3035860T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4442999A DE4442999A1 (de) 1994-12-02 1994-12-02 Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
PCT/EP1995/004761 WO1996016641A1 (de) 1994-12-02 1995-12-04 Transdermale darreichungsform mit antihistaminisch wirksamen loratidinmetabolit

Publications (1)

Publication Number Publication Date
GR3035860T3 true GR3035860T3 (en) 2001-08-31

Family

ID=6534786

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400711T GR3035860T3 (en) 1994-12-02 2001-05-15 Transdermal preparation containing a loratidine metabolite with antihistaminic activity

Country Status (11)

Country Link
US (2) US6165498A (el)
EP (1) EP0794770B1 (el)
AT (1) ATE199496T1 (el)
AU (1) AU4301596A (el)
DE (2) DE4442999A1 (el)
DK (1) DK0794770T3 (el)
ES (1) ES2156220T3 (el)
GR (1) GR3035860T3 (el)
PT (1) PT794770E (el)
WO (1) WO1996016641A1 (el)
ZA (1) ZA9510234B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
AU776837B2 (en) * 1997-02-07 2004-09-23 Sunovion Pharmaceuticals Inc. Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
CA2288726C (en) * 1997-04-25 2008-04-01 Schering-Plough Kabushiki Kaisha Eyedrops containing a loratadine metabolite
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
DE60141596D1 (de) 2000-10-23 2010-04-29 Euro Celtique Sa Transdermales system zur verabreichung von loratadin und dessen verwendung
DE10360592A1 (de) * 2003-12-19 2005-07-28 Beiersdorf Ag Pflastersystem zur Verabreichung von Antihistaminika
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
KR102081925B1 (ko) 2012-08-29 2020-02-26 엘지전자 주식회사 디스플레이 디바이스 및 스피치 검색 방법
DE202018106738U1 (de) * 2018-11-27 2018-12-06 Amoena Medizin-Orthopädie-Technik GmbH Kompressions-Büstenhalter zur postoperativen Versorgung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten

Also Published As

Publication number Publication date
PT794770E (pt) 2001-08-30
WO1996016641A1 (de) 1996-06-06
US6395297B1 (en) 2002-05-28
DK0794770T3 (da) 2001-04-17
DE59509084D1 (de) 2001-04-12
AU4301596A (en) 1996-06-19
ZA9510234B (en) 1996-09-02
ATE199496T1 (de) 2001-03-15
US6165498A (en) 2000-12-26
EP0794770A1 (de) 1997-09-17
ES2156220T3 (es) 2001-06-16
EP0794770B1 (de) 2001-03-07
DE4442999A1 (de) 1996-06-05

Similar Documents

Publication Publication Date Title
GR3035860T3 (en) Transdermal preparation containing a loratidine metabolite with antihistaminic activity
NO941593D0 (el)
GB2282366B (en) Device for delivering an audible message
DE60106235D1 (de) Mit medikamenten gefülltes transdermales reservoir und verfahren zu seiner herstellung
EP0597536A3 (en) Active matrix display devices.
EP1014979A4 (en) CONNECTIONS WITH COMBINED ANTIHISTAMINIC AND FAST-CELL STABILIZING ACTIVITY FOR OPHTHALMOLOGICAL USE
DE69022825D1 (de) Prismatischer gasdichter alkalischer Akkumulator mit wasserstoffspeichernde Legierung enthaltender negativer Elektrode.
MY134888A (en) Optically active isomers of ketotifen and therapeutically active metabolites thereof
EP0660160A4 (en) ACTIVE MATRIX DISPLAY DEVICE.
EP0727482A3 (de) Verfahren für die Kultivierung von Zellen auf einem Träger, Vorrichtung zur Durchführung des Verfahrens und Verwendung der Vorrichtung
NZ332215A (en) Transdermally administered dextromethorphan as antitussive agent
ZA200000171B (en) Analgesic with controlled active substance release.
TW355847B (en) A surface treatment steel plate used for battery case, batterycase and battery using the case
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
WO1996025956A3 (de) Konjugat zur individuellen dosierung von arzneimitteln
FI894401A (fi) Avstaengningsmekanism foer kanaler med stora tvaersnitt, speciellt roekgaskanaler foer kraftverk.
AU642896B2 (en) Arylpyrrole insecticidal, acaricidal and nematicidal agents and methods
EP0488808A3 (en) An active matrix substrate
HK1035961A1 (en) A septum for battery and the battery using the same.
BG102692A (en) Pharmaceutical forms with delayed release, containing misolastin
AU1932997A (en) Dosage forms and uses
GB9711032D0 (en) Compound as a stimulant for the central nervous system
EP0948961A3 (de) Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff
ES2141044A1 (es) Terapia con oxibutinina.
AU4095393A (en) Device for altering the activity of a biological cell

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees